Leading the Way in Contamination Control Products for use in Critical Environments
See How Contec’s solutions meet and exceed USP standards
Hazardous Drugs in Healthcare Settings
USP Chapter <800>
See how Contec solutions are right for you.
Contact us today
BACK TO TOP
BACK: USP CHAPTER <797>
Explore Our Products and Solutions
Clean Counts Most: Contec Healthcare’s solutions – designed with end users in mind – promote more efficient, repeatable processes and deliver improved cleaning results for better patient outcomes.
NEXT: USP CHAPTER <825>
Deactivation renders a compound inert or inactive.
The ultimate goal should be complete surface decontamination.
Products that have known deactivation properties (EPA-Registered oxidizing agents that are appropriate for the intended use) should be used when possible.
Care should be taken when selecting materials for deactivation due to potential adverse effects (hazardous byproducts, respiratory effects and caustic damage to surfaces).
Damage to surfaces is exhibited by corrosion to stainless steel surfaces caused by sodium hypochlorite if left untreated.
PeridoxRTU is a broad spectrum EPA-registered sporicide, bactericide, virucide, tuberculocide, and fungicide one-step disinfectant and hard surface cleaner with a 3 minute sporicide claim at 99.9999% efficacy. Compatible with most surfaces found in the sterile compounding environment, PeridoxRTU provides maximum effectiveness as an essential part of Contec’s C-D3 ™ protocol.
Contec Healthcare’s C-D3™ protocol decontaminates HD residues in sterile compounding settings.
Decontamination occurs by inactivating, neutralizing, or physically removing HD residue from non-disposable surfaces and transferring it to absorbent materials (e.g., wipes, pads or towels) appropriate to the area being cleaned.
When choosing among various products available for decontaminating HDs, consideration should be given to surface compatibility and facility requirements.
Cleaning is a process that results in the removal of contaminants (e.g., soil, microbial contamination, HD residue) from objects and surfaces using water, detergents, surfactants, solvents and/or other chemicals.
Cleaning agents used on compounding equipment should not introduce microbial contamination.
Disinfection is a process of inhibiting or destroying microorganisms.
Before disinfection can be adequately performed, surfaces must be cleaned.
Disinfection must be done for areas intended to be sterile, including the sterile compounding areas.
PeridoxRTU is a broad spectrum EPA-registered sporicide, bactericide, virucide, tuberculocide, and fungicide one-step disinfectant and hard surface cleaner with a 3 minute sporicide claim at 99.9999% efficacy. Compatible with most surfaces found in the sterile compounding environment, PeridoxRTU provides maximum effectiveness as an essential part of Contec’s C-D3 ™ protocol. Also available in sterile.
See C-D3™ steps
See product details
Download Contec Healthcare’s USP <800> Guide
Contec is committed to providing quality, research and experience-driven consumables for critical compounding areas.
It’s our mission to protect employees, patients, and the compounding environment from exposure to hazardous drugs.
USP CHAPTER <797>
USP CHAPTER <800>
USP CHAPTER <825>
USP <800> strives to protect personnel and the environment when handling Hazardous Drugs (HDs). Understanding the definitions, best practices, and recommended solutions are key to meeting the USP <800> standards.
NEXT: USP CHAPTER <825>
BACK TO TOP